2016
DOI: 10.1111/jdv.13964
|View full text |Cite
|
Sign up to set email alerts
|

An acneiform eruption exhibiting locus minoris resistentiae after whole‐brain radiation and vemurafenib therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
1
0
1
Order By: Relevance
“…En cambio, se han descrito hasta en un 77% de los pacientes tratados en monoterapia con el inhibidor MEK trametinib [5]. En la literatura hay descritos 5 casos de reacciones acneiformes tras tratamiento con vemurafenib [6,7,8]. Todas ellas se iniciaron en menos de 5 semanas de inicio del tratamiento y la mayoría de ellas respondió a tratamiento tópico u observación [6].…”
Section: Case Discussionunclassified
“…En cambio, se han descrito hasta en un 77% de los pacientes tratados en monoterapia con el inhibidor MEK trametinib [5]. En la literatura hay descritos 5 casos de reacciones acneiformes tras tratamiento con vemurafenib [6,7,8]. Todas ellas se iniciaron en menos de 5 semanas de inicio del tratamiento y la mayoría de ellas respondió a tratamiento tópico u observación [6].…”
Section: Case Discussionunclassified
“…An easy transit and access of lymphocytes to cutaneous antigens through the damaged dermal matrix in the striae might be a plausible explanation for this occurrence. Chemotherapy-induced skin eruptions localized to radiotherapy site 4 and melanoma metastasis; 5 as well as infective conditions like verruca 6 and tinea barbae 7 localized to verrucous epidermal nevus and scar tissue, respectively, are other examples of locus minoris resistentiae. Fixed drug reaction secondary to minocycline localizing to areas of herpes zoster and burn scars has also been described.…”
Section: Figurementioning
confidence: 99%